Company · Private
Adela, Inc.
Key figures
- SEC number
- 1852167
Source: SEC EDGAR filings and company facts; checked 20 Oct 2026
About
Adela develops blood tests that detect cancer and other serious diseases by analysing DNA methylation patterns in cell-free DNA.
Rounds and raises
19 Oct 2026
Form D: $12M sold of $12M offered, Biotechnology SEC
23 Apr 2026
Form D: $5M sold of $5M offered, Biotechnology SEC
Source: SEC EDGAR Form D and the linked articles. All raises this week
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.